Why does everyone hate biotech stocks? Can Big Science create an actual business? And what are Martin Shkreli’s job prospects?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. With biotech in the dumps, we talk to Oppenheimer analyst Jared Holz about why the world has soured on the sector and what it means for the future of medicine. Then, STAT’s Matthew Herper joins us to explain the latest big idea from biotech’s big thinkers: a company called Altos Labs, which has raised $3 billion to do something or other. We also discuss the latest news in the life sciences, with a cameo from Shkreli and an update on Omicron.
Early Bird Access Extended: The Breakthrough Science Summit
For one more week only, access our best rates! On March 31, we're gathering knowledgeable insiders - from pharma executives to cutting-edge researchers - to hear their takes on the innovations in tech and procedures that are set to change the face of health and medicine. Early bird pricing ends Friday, Jan. 21 so get your pass now!
No comments